https://endpts.com/breaking-not-known-for-gene-therapy-plays-eli-lilly-acquires-hearing-loss-startup-akouos-for-487m-plus-cvr/
0
0
10/18/22 at 11:33am
Organization
Endpoints News
Author
Max Gelman
Eli Lilly is jumping into gene therapies for the ear. The Big Pharma announced early Tuesday that it will acquire Boston biotech Akouos for a 78% premium over Monday’s closing price. Akouos closed at $7.01 per share Monday afternoon, while Lilly is paying $12…
Create an account
or login to join the discussion